AU Stock MarketDetailed Quotes
CYP Cynata Therapeutics Ltd
- 0.310
- -0.025-7.46%
20min DelayNot Open Jun 14 16:00 AET
55.69MMarket Cap-3163P/E (Static)
0.330High0.310Low219.49KVolume0.330Open0.335Pre Close69.62KTurnover0.34552wk High0.17%Turnover Ratio179.63MShares0.10552wk Low-0.088EPS TTM40.94MFloat Cap0.640Historical HighLossP/E (Static)132.07MShs Float0.105Historical Low-0.098EPS LYR5.97%Amplitude--Dividend TTM4.56P/B1Lot Size--Div YieldTTM
About Cynata Therapeutics Ltd Company
Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus. There are currently three active clinical trials taking place using Cymerus technology which are attempting to treat osteoarthritis, respiratory distress, and diabetic foot ulcers.
Company Profile
SymbolCYP
Company NameCynata Therapeutics Ltd
Founded2003
MarketASX
Employees2
Fiscal Year Ends06-30
Address100 Cubitt Street Level 3
CityCremorne
CountryAustralia
Zip Code3121
Phone+61 370676940
Websitehttps://www.cynata.com
Company Executives
- Name
- Position
- Salary
- Ross Macdonald
- Chief Executive Officer,Managing Director
- --
- Geoffrey E.D Brooke
- Non-Executive Director,Non-Executive Chairman
- --
- David Atkins
- Non-Executive Director
- --
- Darryl Maher
- Non-Executive Director
- --
- Stewart James Washer
- Non-Executive Director
- --
- Paul K Wotton
- Non-Executive Director
- --
- Janine Rolfe
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg